Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Allogene Therapeutics
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Chinese PLA General Hospital
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Chicago
Ossium Health, Inc.
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Baylor College of Medicine
M.D. Anderson Cancer Center
Thomas Jefferson University
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Chinese PLA General Hospital
Chinese PLA General Hospital
Chinese PLA General Hospital
Ohio State University Comprehensive Cancer Center
University Hospital Schleswig-Holstein
Anhui Provincial Hospital
The Affiliated People's Hospital of Ningbo University